4CF-19148-31269
4 vaccinations
2 coded responses
40 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 379 / TN
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
-
2020-12-18
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2020-12-19
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2020-12-20
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2020-12-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2020-12-22
- 2020-12-27
- 2021-01-01
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-01-08
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · HeadacheAdult check-in
- 2021-01-15
- 2021-01-24
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-04-09
- 2021-07-09
-
2021-12-06
Dose 3 — Pfizer-BioNTech
-
2021-12-06
Health check-in — day 0, dose 3Feeling: Good · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-12-08
- 2021-12-10
- 2021-12-11
- 2021-12-12
- 2021-12-13
- 2021-12-20
- 2021-12-27
- 2022-01-03
- 2022-01-10
- 2022-01-17
- 2022-03-07
- 2022-06-06
-
2022-10-24
Dose 4 — Pfizer-BioNTech
- 2022-11-02
- 2022-11-07
- 2022-11-14
- 2022-11-21
- 2022-11-28
- 2022-12-05
-
2023-01-23
Survey response — 3 months, dose 4MedDRA: Astrocytoma, Brain neoplasm, Glioma — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
-
2023-04-24
Survey response — 6 months, dose 4MedDRA: Astrocytoma, Brain neoplasm — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-12-06 | Pfizer-BioNTech | No |
| 4 | 2022-10-24 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-09 | priority 2/3 |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Astrocytoma | · | · | ✓ |
| SD | Brain neoplasm | · | · | ✓ |
| SD | Glioma | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release